Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kirsch

Showing results (11-20 of 357) with videos related to

Pageof 36
Sort By:
Disease Models & Mechanisms|July 18, 2015
The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesisMinsi Zhang, David G Kirsch
Eclinicalmedicine|May 31, 2019
Safely combining trabectedin with radiotherapy to treat myxoid liposarcomaMark Chen, David G Kirsch
Disease Models & Mechanisms|December 10, 2016
Retraction: The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesisMinsi Zhang, David G Kirsch
Pediatric Blood & Cancer|March 30, 2004
New technologies in radiation therapy for pediatric brain tumors: the rationale for proton radiation therapyDavid G Kirsch, Nancy J Tarbell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Targeting HER2 in brain metastases from breast cancerDavid G Kirsch, Fred H Hochberg
Expert Review of Neurotherapeutics|April 28, 2005
Treating brain metastases: current approaches and future directionsDavid G Kirsch, Jay S Loeffler
Clinical Psychology Review|March 9, 2007
Emotional deficits in psychopathy and sexual sadism: implications for violent and sadistic behaviorLaura G Kirsch, Judith V Becker
Pediatric Dentistry|January 1, 1994
Hemangiopericytoma of the tongue in an 11-year-old girl: case report and literature reviewO Hasson, G Kirsch, J Lustmann
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
The Holman Research Pathway in radiation oncologyJoanne B Weidhaas, David G Kirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Tumor-suppressor p53: implications for tumor development and prognosisD G Kirsch, M B Kastan
Pageof 36

Showing results (11-20 of 357) with videos related to

Sort By:
Pageof 36
Disease Models & Mechanisms|July 18, 2015
The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesisMinsi Zhang, David G Kirsch
Eclinicalmedicine|May 31, 2019
Safely combining trabectedin with radiotherapy to treat myxoid liposarcomaMark Chen, David G Kirsch
Disease Models & Mechanisms|December 10, 2016
Retraction: The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesisMinsi Zhang, David G Kirsch
Pediatric Blood & Cancer|March 30, 2004
New technologies in radiation therapy for pediatric brain tumors: the rationale for proton radiation therapyDavid G Kirsch, Nancy J Tarbell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Targeting HER2 in brain metastases from breast cancerDavid G Kirsch, Fred H Hochberg
Expert Review of Neurotherapeutics|April 28, 2005
Treating brain metastases: current approaches and future directionsDavid G Kirsch, Jay S Loeffler
Clinical Psychology Review|March 9, 2007
Emotional deficits in psychopathy and sexual sadism: implications for violent and sadistic behaviorLaura G Kirsch, Judith V Becker
Pediatric Dentistry|January 1, 1994
Hemangiopericytoma of the tongue in an 11-year-old girl: case report and literature reviewO Hasson, G Kirsch, J Lustmann
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
The Holman Research Pathway in radiation oncologyJoanne B Weidhaas, David G Kirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Tumor-suppressor p53: implications for tumor development and prognosisD G Kirsch, M B Kastan
Pageof 36